Steven Rychnovsky
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$450KFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $450K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 17, 2020 | NIH | STTR Phase I Photodynamic Therapy to Prevent Arteriovenous Fistula Maturation Failure | $225K | ADGERO BIOPHARMACEUTICALS HOLDINGS INC |
| Jul 17, 2020 | NIH | STTR Phase I Photodynamic Therapy to Prevent Arteriovenous Fistula Maturation Failure | $225K | ADGERO BIOPHARMACEUTICALS HOLDINGS INC with UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
Peer ranks
Federal funding#2,871
Awards as PI#1,503
Patents#505
Companies
- ADGERO BIOPHARMACEUTICALS HOLDINGS INCLinked by awards · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.